Medscape shares a doctor's account of a late-night call tied to retatrutide bought outside approved channels, and the warning that came from it.
Recap by typeshit. Full story at Medscape.
European regulators first raised NAION, a rare optic nerve condition sometimes called an eye stroke, as a possible risk more than 15 months ago.
Obesity doctor Spencer Nadolsky takes on six popular misconceptions about Ozempic in a quick social video. The caption doesn't say which myths are covered.
Users described more appetite, fatigue, extra energy and insomnia. An analysis of Reddit comments, not a clinical trial, so the findings come from self-reports.
A piece on questions about tirzepatide and breast cancer risk. Only the headline is available, so check the source for what the evidence says.
TCTMD covers new data on two next-generation drugs, retatrutide and survodutide, for weight loss in diabetic patients. Tap through for the trial details.
Researchers tested the combination in vivo and report lower peripheral immune activation and fewer inflammatory gene signatures in the central nervous system.
Loading…